PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'Department of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.\', \'Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Baltimore, Maryland, USA.\', \'Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.\', \'Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA olaeyen1@jhmi.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • e02257-2010.1128/JCM.02257-20
?:doi
?:hasPublicationType
?:journal
  • Journal of clinical microbiology
is ?:pmid of
?:pmid
?:pmid
  • 33139419
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.256
?:rankingScore_hIndex
  • 226
?:title
  • Comparative Performance of Five Commercially Available Serologic Assays To Detect Antibodies to SARS-CoV-2 and Identify Individuals with High Neutralizing Titers.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all